263 related articles for article (PubMed ID: 20236230)
21. Phosphatidylinositol 3-kinase is an upstream regulator of the phosphodiesterase 3B pathway of leptin signalling that may not involve activation of Akt in the rat hypothalamus.
Sahu A; Koshinaka K; Sahu M
J Neuroendocrinol; 2013 Feb; 25(2):168-79. PubMed ID: 22967108
[TBL] [Abstract][Full Text] [Related]
22. Distinct and opposing roles for the phosphatidylinositol 3-OH kinase catalytic subunits p110α and p110β in the regulation of insulin secretion from rodent and human beta cells.
Kolic J; Spigelman AF; Plummer G; Leung E; Hajmrle C; Kin T; Shapiro AM; Manning Fox JE; MacDonald PE
Diabetologia; 2013 Jun; 56(6):1339-49. PubMed ID: 23568272
[TBL] [Abstract][Full Text] [Related]
23. The dietary flavonoids naringenin and quercetin acutely impair glucose metabolism in rodents possibly via inhibition of hypothalamic insulin signalling.
Koch CE; Ganjam GK; Steger J; Legler K; Stöhr S; Schumacher D; Hoggard N; Heldmaier G; Tups A
Br J Nutr; 2013 Mar; 109(6):1040-51. PubMed ID: 22850125
[TBL] [Abstract][Full Text] [Related]
24. Leptin and insulin stimulation of signalling pathways in arcuate nucleus neurones: PI3K dependent actin reorganization and KATP channel activation.
Mirshamsi S; Laidlaw HA; Ning K; Anderson E; Burgess LA; Gray A; Sutherland C; Ashford ML
BMC Neurosci; 2004 Dec; 5():54. PubMed ID: 15581426
[TBL] [Abstract][Full Text] [Related]
25. Specific role for p85/p110beta in GTP-binding-protein-mediated activation of Akt.
Kubo H; Hazeki K; Takasuga S; Hazeki O
Biochem J; 2005 Dec; 392(Pt 3):607-14. PubMed ID: 16091017
[TBL] [Abstract][Full Text] [Related]
26. Dynamics of GFP-Fusion p110α and p110β Isoforms of PI3K Signaling Pathway in Normal and Cancer Cells.
Singh P; Dar MS; Singh G; Jamwal G; Sharma PR; Ahmad M; Dar MJ
J Cell Biochem; 2016 Dec; 117(12):2864-2874. PubMed ID: 27167447
[TBL] [Abstract][Full Text] [Related]
27. Combined Inhibition of Both p110α and p110β Isoforms of Phosphatidylinositol 3-Kinase Is Required for Sustained Therapeutic Effect in PTEN-Deficient, ER
Hosford SR; Dillon LM; Bouley SJ; Rosati R; Yang W; Chen VS; Demidenko E; Morra RP; Miller TW
Clin Cancer Res; 2017 Jun; 23(11):2795-2805. PubMed ID: 27903677
[No Abstract] [Full Text] [Related]
28. A drug targeting only p110α can block phosphoinositide 3-kinase signalling and tumour growth in certain cell types.
Jamieson S; Flanagan JU; Kolekar S; Buchanan C; Kendall JD; Lee WJ; Rewcastle GW; Denny WA; Singh R; Dickson J; Baguley BC; Shepherd PR
Biochem J; 2011 Aug; 438(1):53-62. PubMed ID: 21668414
[TBL] [Abstract][Full Text] [Related]
29. p110α and p110β isoforms of PI3K are involved in protection against H
Singh P; Bano N; Hossain MM; Basit R; Dar MJ
Breast Cancer; 2019 May; 26(3):378-385. PubMed ID: 30499025
[TBL] [Abstract][Full Text] [Related]
30. Phosphoinositide 3-kinases p110α and p110β have differential roles in insulin-like growth factor-1-mediated Akt phosphorylation and platelet priming.
Blair TA; Moore SF; Williams CM; Poole AW; Vanhaesebroeck B; Hers I
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1681-8. PubMed ID: 24903091
[TBL] [Abstract][Full Text] [Related]
31. Galanin-like peptide (GALP) neurone-specific phosphoinositide 3-kinase signalling regulates GALP mRNA levels in the hypothalamus of males and luteinising hormone levels in both sexes.
Aziz R; Beymer M; Negrón AL; Newshan A; Yu G; Rosati B; McKinnon D; Fukuda M; Lin RZ; Mayer C; Boehm U; Acosta-Martínez M
J Neuroendocrinol; 2014 Jul; 26(7):426-38. PubMed ID: 24796383
[TBL] [Abstract][Full Text] [Related]
32. Central leptin action improves skeletal muscle AKT, AMPK, and PGC1 alpha activation by hypothalamic PI3K-dependent mechanism.
Roman EA; Reis D; Romanatto T; Maimoni D; Ferreira EA; Santos GA; Torsoni AS; Velloso LA; Torsoni MA
Mol Cell Endocrinol; 2010 Jan; 314(1):62-9. PubMed ID: 19698760
[TBL] [Abstract][Full Text] [Related]
33. The catalytic class I(A) PI3K isoforms play divergent roles in breast cancer cell migration.
De Laurentiis A; Pardo OE; Palamidessi A; Jackson SP; Schoenwaelder SM; Reichmann E; Scita G; Arcaro A
Cell Signal; 2011 Mar; 23(3):529-41. PubMed ID: 21056654
[TBL] [Abstract][Full Text] [Related]
34. Class IA Phosphatidylinositol 3-Kinase Isoform p110α Mediates Vascular Remodeling.
Vantler M; Jesus J; Leppänen O; Scherner M; Berghausen EM; Mustafov L; Chen X; Kramer T; Zierden M; Gerhardt M; Ten Freyhaus H; Blaschke F; Sterner-Kock A; Baldus S; Zhao JJ; Rosenkranz S
Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1434-44. PubMed ID: 25908763
[TBL] [Abstract][Full Text] [Related]
35. Enhanced Akt phosphorylation and myogenic differentiation in PI3K p110β-deficient myoblasts is mediated by PI3K p110α and mTORC2.
Matheny RW; Lynch CM; Leandry LA
Growth Factors; 2012 Dec; 30(6):367-84. PubMed ID: 23137199
[TBL] [Abstract][Full Text] [Related]
36. Both p110α and p110β isoforms of PI3K can modulate the impact of loss-of-function of the PTEN tumour suppressor.
Berenjeno IM; Guillermet-Guibert J; Pearce W; Gray A; Fleming S; Vanhaesebroeck B
Biochem J; 2012 Feb; 442(1):151-9. PubMed ID: 22150431
[TBL] [Abstract][Full Text] [Related]
37. Acute physical exercise increases PI3K-p110α protein content in the hypothalamus of obese mice.
Gaspar RC; Nakandakari SCBR; Muñoz VR; Vieira RFL; da Silva ASR; Cintra DE; de Moura LP; Ropelle ER; Pauli JR
J Anat; 2021 Mar; 238(3):743-750. PubMed ID: 33094520
[TBL] [Abstract][Full Text] [Related]
38. Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis.
Jia S; Liu Z; Zhang S; Liu P; Zhang L; Lee SH; Zhang J; Signoretti S; Loda M; Roberts TM; Zhao JJ
Nature; 2008 Aug; 454(7205):776-9. PubMed ID: 18594509
[TBL] [Abstract][Full Text] [Related]
39. Over-expression of the p110beta but not p110alpha isoform of PI 3-kinase inhibits motility in breast cancer cells.
Yip SC; El-Sibai M; Hill KM; Wu H; Fu Z; Condeelis JS; Backer JM
Cell Motil Cytoskeleton; 2004 Nov; 59(3):180-8. PubMed ID: 15468162
[TBL] [Abstract][Full Text] [Related]
40. Isoform-specific phosphoinositide 3-kinase inhibitors exert distinct effects in solid tumors.
Edgar KA; Wallin JJ; Berry M; Lee LB; Prior WW; Sampath D; Friedman LS; Belvin M
Cancer Res; 2010 Feb; 70(3):1164-72. PubMed ID: 20103642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
